342 related articles for article (PubMed ID: 26753656)
1. Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: a pilot study.
Rago R; Marcucci I; Leto G; Caponecchia L; Salacone P; Bonanni P; Fiori C; Sorrenti G; Sebastianelli A
J Biol Regul Homeost Agents; 2015; 29(4):913-23. PubMed ID: 26753656
[TBL] [Abstract][Full Text] [Related]
2. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Papaleo E; Unfer V; Baillargeon JP; Fusi F; Occhi F; De Santis L
Fertil Steril; 2009 May; 91(5):1750-4. PubMed ID: 18462730
[TBL] [Abstract][Full Text] [Related]
3. Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature.
Regidor PA; Schindler AE; Lesoine B; Druckman R
Horm Mol Biol Clin Investig; 2018 Mar; 34(2):. PubMed ID: 29498933
[TBL] [Abstract][Full Text] [Related]
4. Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome.
Pacchiarotti A; Carlomagno G; Antonini G; Pacchiarotti A
Gynecol Endocrinol; 2016; 32(1):69-73. PubMed ID: 26507336
[TBL] [Abstract][Full Text] [Related]
5. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
Rizzo P; Raffone E; Benedetto V
Eur Rev Med Pharmacol Sci; 2010 Jun; 14(6):555-61. PubMed ID: 20712264
[TBL] [Abstract][Full Text] [Related]
6. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study.
Unfer V; Raffone E; Rizzo P; Buffo S
Gynecol Endocrinol; 2011 Nov; 27(11):857-61. PubMed ID: 21463230
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of a new association between insulin-sensitizers and α-lipoic acid in obese women affected by PCOS].
Cappelli V; Di Sabatino A; Musacchio MC; De Leo V
Minerva Ginecol; 2013 Aug; 65(4):425-33. PubMed ID: 24051942
[TBL] [Abstract][Full Text] [Related]
9. Effects of α-lipoic acid and myo-inositol supplementation on the oocyte environment of infertile obese women: A preliminary study.
Novielli C; Anelli GM; Lisso F; Marzorati A; Parrilla B; Oneta M; Savasi VM; Cetin I; Mandò C
Reprod Biol; 2020 Dec; 20(4):541-546. PubMed ID: 33371944
[TBL] [Abstract][Full Text] [Related]
10. The myo-inositol effect on the oocyte quality and fertilization rate among women with polycystic ovary syndrome undergoing assisted reproductive technology cycles: a randomized clinical trial.
Akbari Sene A; Tabatabaie A; Nikniaz H; Alizadeh A; Sheibani K; Mortezapour Alisaraie M; Tabatabaie M; Ashrafi M; Amjadi F
Arch Gynecol Obstet; 2019 Jun; 299(6):1701-1707. PubMed ID: 30919036
[TBL] [Abstract][Full Text] [Related]
11. d-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS.
Cianci A; Panella M; Fichera M; Falduzzi C; Bartolo M; Caruso S
Gynecol Endocrinol; 2015 Jun; 31(6):483-6. PubMed ID: 25893270
[TBL] [Abstract][Full Text] [Related]
12. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
Unfer V; Carlomagno G; Rizzo P; Raffone E; Roseff S
Eur Rev Med Pharmacol Sci; 2011 Apr; 15(4):452-7. PubMed ID: 21608442
[TBL] [Abstract][Full Text] [Related]
13. The effect of myo-inositol/di-chiro-inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta-analysis.
Bhide P; Pundir J; Gudi A; Shah A; Homburg R; Acharya G
Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1235-1244. PubMed ID: 30993683
[TBL] [Abstract][Full Text] [Related]
14. Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials.
Mendoza N; Pérez L; Simoncini T; Genazzani A
Reprod Biomed Online; 2017 Nov; 35(5):529-535. PubMed ID: 28756130
[TBL] [Abstract][Full Text] [Related]
15. HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA).
Cirillo F; Catellani C; Lazzeroni P; Sartori C; Tridenti G; Vezzani C; Fulghesu AM; Madeddu E; Amarri S; Street ME
Gynecol Endocrinol; 2020 Jul; 36(7):588-593. PubMed ID: 32054355
[TBL] [Abstract][Full Text] [Related]
16. The effect of Myo-Inositol supplement on molecular regulation of folliculogenesis, steroidogenesis, and assisted reproductive technique outcomes in patients with polycystic ovarian syndrome.
Tabatabaie M; Amiri S; Golestan Jahromi M; Sene AA; Zandieh Z; Mehdizadeh M; Amjadi F
Mol Biol Rep; 2022 Feb; 49(2):875-884. PubMed ID: 35040006
[TBL] [Abstract][Full Text] [Related]
17. Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both.
Genazzani AD; Prati A; Marchini F; Petrillo T; Napolitano A; Simoncini T
Gynecol Endocrinol; 2019 Dec; 35(12):1088-1093. PubMed ID: 31304823
[TBL] [Abstract][Full Text] [Related]
18. Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies.
Merviel P; James P; Bouée S; Le Guillou M; Rince C; Nachtergaele C; Kerlan V
Reprod Health; 2021 Jan; 18(1):13. PubMed ID: 33468143
[TBL] [Abstract][Full Text] [Related]
19. Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action.
De Cicco S; Immediata V; Romualdi D; Policola C; Tropea A; Di Florio C; Tagliaferri V; Scarinci E; Della Casa S; Lanzone A; Apa R
Gynecol Endocrinol; 2017 Sep; 33(9):698-701. PubMed ID: 28434274
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study.
Lisi F; Carfagna P; Oliva MM; Rago R; Lisi R; Poverini R; Manna C; Vaquero E; Caserta D; Raparelli V; Marci R; Moscarini M
Reprod Biol Endocrinol; 2012 Jul; 10():52. PubMed ID: 22823904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
